Science Explorer Interactive view Map

ARCA Biopharma (United States)

Research works
23
▼ 54% vs 2013–17
Citations
421
18.4 per fractional work
Top-10% rate
23.4%
record average 16.5%
Open access
35%
world 28%

Not ranked overall: ARCA Biopharma (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.68× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.66× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 1.38× its world share, 0 worksImmunology and Micro…Engineering: 1.79× its world share, 1 worksEngineeringEnvironmental Science: 1.96× its world share, 0 worksEnvironmental ScienceMedicine: 2.88× its world share, 2 worksMedicineworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Medicine, 2.9×. Every wedge is a field page.

Which keywords describe research at ARCA Biopharma (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cardiovascular Disease, Chronic Kidney Disease, Heart Failure, Renal Function, Guidelines, Treatment, Fibrosis and Diagnosis.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 31 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 31 words, with their numbers
  1. Cardiovascular Disease3▲ 13×8 topics
  2. Chronic Kidney Disease3▲ 57×4 topics
  3. Heart Failure3▲ 30×8 topics
  4. Epidemiology3▲ 2.8×7 topics
  5. Renal Function2▲ 93×3 topics
  6. Guidelines2▲ 20×5 topics
  7. Treatment2▲ 7.1×4 topics
  8. Diagnosis2▲ 7.8×4 topics
  9. Fibrosis2▲ 41×4 topics
  10. B-Type Natriuretic Peptide2▲ 150×1 topic
  11. Hospital Readmission2▲ 150×1 topic
  12. Metabolic Syndrome2▲ 7.6×5 topics
  13. Calcium Signaling1▲ 47×3 topics
  14. Cell Signaling1▲ 18×3 topics
  15. Inflammation1▲ 2.6×9 topics
  16. Arrhythmias1▲ 43×2 topics
  17. Biomarkers1▲ 9.4×2 topics
  18. Genetic Testing1▲ 36×2 topics
  19. Acute Kidney Injury1▲ 103×1 topic
  20. Cardiac Electrophysiology1▲ 69×1 topic
  21. Crystal Structure1▲ 21×1 topic
  22. G-Protein-Coupled Receptors1▲ 65×1 topic
  23. Ion Channels1▲ 25×2 topics
  24. Long-QT Syndrome1▲ 69×1 topic
  25. Oxidative Stress1▲ 2.9×7 topics
  26. Renal Failure1▲ 118×1 topic
  27. Sudden Cardiac Death1▲ 45×2 topics
  28. Cardiovascular Risk1▲ 13×2 topics
  29. Diabetic Nephropathy1▲ 69×1 topic
  30. Global Burden1▲ 9.0×2 topics
  31. Glomerular Filtration Rate1▲ 144×1 topic

Which research topics does ARCA Biopharma (United States) publish most on?

By volume in 2022–2025: Viral Infections and Immunology Research, Cardiac electrophysiology and arrhythmias, Mining Techniques and Economics and SARS-CoV-2 and COVID-19 Research.

  1. 1 Viral Infections and Immunology Research Cardiology and Cardiovascular Medicine 0 works
  2. 2 Cardiac electrophysiology and arrhythmias Cardiology and Cardiovascular Medicine 0 works
  3. 3 Mining Techniques and Economics Control and Systems Engineering 0 works
  4. 4 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  5. 5 Minerals Flotation and Separation Techniques Water Science and Technology 0 works
  6. 6 Mineral Processing and Grinding Mechanical Engineering 0 works
  7. 7 Tailings Management and Properties Civil and Structural Engineering 0 works
  8. 8 Chronic Kidney Disease and Diabetes Nephrology 0 works
  9. 9 Renin-Angiotensin System Studies Cardiology and Cardiovascular Medicine 0 works
  10. 10 Medical and Biological Ozone Research Pharmacology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available35.3%not open64.7%

World: 28% of research is openly available.

with international co-authors11.9%domestic only88.1%

World: 19% is written across borders.

How has ARCA Biopharma (United States)'s research output changed?

Output in 2018–2022 was 54% lower than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Westminster

All research institutions in Westminster

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.